Patents
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
01/2002
01/24/2002WO2002005834A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions
01/24/2002WO2002005815A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
01/24/2002DE10034130A1 Heterocyclische Fluoralkenylthioether (lV) Heterocyclic fluoroalkenyl thioethers (IV)
01/24/2002CA2415285A1 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds
01/24/2002CA2414780A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
01/24/2002CA2414674A1 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
01/22/2002US6340764 Reference compound for use in the analysis of levosimendan batches
01/22/2002US6340684 Phthalazine derivatives as phosphodiesterase 4 inhibitors
01/17/2002WO2002004427A1 Phenylpyridazine derivatives and drugs containing the same
01/17/2002US20020007062 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
01/17/2002US20020006925 Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors
01/17/2002DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments
01/17/2002CA2413042A1 Phenylpyridazine derivatives and drugs containing the same
01/16/2002EP1171425A1 Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins
01/10/2002WO2001034603A3 Bicyclic and tricyclic heteroaromatic compounds
01/09/2002EP1169312A2 Glucokinase activators
01/03/2002WO2002000661A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS
01/03/2002WO2002000622A2 Aminoalcohol derivatives
01/03/2002WO2002000220A1 A method for treating septic shock
01/03/2002US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide
01/02/2002EP1165547A1 Substituted benzoylpyrazoles as herbicides
01/02/2002EP1165520A1 Method for producing 4-amino-5-chloro-1-phenyl pyridazinone-(6)
01/01/2002US6335445 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
12/2001
12/25/2001US6333413 Pyridazin-3-one derivatives by cyclizing the carboxy-substituted hydrazone
12/20/2001WO2001074788A8 2-hydroxy-mutilin carbamate derivatives for antibacterial use
12/19/2001EP1164128A1 4-Cyanophenyliminoheterocycles
12/19/2001EP0847391B1 Aromatic compounds and pharmaceutical compositions containing them
12/19/2001CN1327443A Substituted anilides
12/18/2001US6331640 Diaminopropionic acid derivatives
12/18/2001US6331553 Inhibitors of nitric oxide synthase; treating cerebrovascular diseases
12/18/2001US6331543 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
12/18/2001CA2018769C Adduct-aldehyde and its use for the preparation of a vitamin-d compound
12/13/2001WO2001094319A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
12/13/2001CA2411351A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
12/12/2001CN1076020C Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation method and compositions
12/11/2001US6329370 Cardiovascular disorders and tumor necrosis factor (hereinafter tnf.sub..alpha.), a cytokine with pro-inflammatory activity
12/11/2001CA1341325C Triazole antifungal agents
12/06/2001WO2001092258A1 Imidazoloisoquinolines
11/2001
11/29/2001WO2001090071A2 Substituted iminoazines used as herbicides
11/29/2001CA2409142A1 Substituted iminoazines
11/28/2001CN1324350A Benzoylpyridazines
11/28/2001CN1075490C O-benzyl oxime ether derivatives and their use in crop production compositions
11/27/2001US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/22/2001WO2001087850A1 Pyridazine derivative elevating pdhactivity
11/22/2001WO2001087845A2 N-containing heterocyclic compounds and their use as 5-ht antagonists
11/22/2001US20010044538 Mitogen-activated protein (MAP) kinase; treating inflammatory diseases; compounds such as 3-(4-fluorophenyl)-1-hydroxy-2-(pyridin-4-yl)-1H-pyrrolo(3,2-b)pyridine
11/22/2001DE10024938A1 New substituted iminoazine derivatives useful as herbicides, especially for weed control in crops
11/21/2001EP1156039A1 Pyridazin-3-one derivatives and medicines containing the same
11/21/2001EP1154773A2 Use of antagonists of pg-e for the treatment of neuropathic pain
11/21/2001EP0650480B1 1-arylsulphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
11/21/2001CN1323297A Pyridazinone derivatives
11/21/2001CN1323291A Diaminopropionic acid derivatives
11/20/2001US6320050 2-substituted phenyl-3-cycloalkyl substituted n-heteroaromatic propionamides; used to increase insulin secretion in the treatment of type ii diabetes.
11/20/2001US6319925 O-benzyl oxime ether derivatives and their use in crop protection compositions
11/15/2001WO2001085670A1 Malonanilic acid derivatives, medicinal compositions containing the same and use thereof
11/15/2001US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/13/2001US6316617 For treating physiological disorders associated with an excess of neuropeptide y, such as feeding disorders and certain cardiovascular diseases, medical diagnosis
11/13/2001US6316464 P38 MAP kinase inhibitors
11/13/2001US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/08/2001WO2001083459A2 Uracil substituted phenyl sulfamoyl carboxamides
11/08/2001WO2001083458A2 Asymmetric synthesis of piperazic acid and derivatives thereof
11/08/2001WO2001083434A2 P-(sulfonyl)-aryl and heteroaryls amines
11/08/2001WO2001083427A1 PPARη MODULATORS
11/08/2001US20010039344 Antidiabetic agents
11/08/2001CA2407587A1 Ppar.gamma. modulators
11/08/2001CA2405832A1 P-(sulfonyl)aryl and heteroaryls
11/08/2001CA2403304A1 Asymmetric synthesis of piperazic acid and derivatives thereof
11/07/2001EP1151998A1 Estrogen agonists/antagonists
11/07/2001EP1150944A1 N2-phenylamidine derivatives
11/07/2001EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/06/2001US6313148 For therapy of pain pain associated with joint conditions such as rheumatoid arthritis and osteoarthritis, postoperative pain, post-partum pain, the pain associated with dental conditions such as dental caries and gingivitis
11/01/2001WO2001081318A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
11/01/2001US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001US20010036945 Certain Isoquinolinamine and phthalazinamine derivatives; corticotropin-releasing factor receptor CRF1 specific ligands
11/01/2001CA2399741A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
10/2001
10/31/2001EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/30/2001US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001US6310065 Pyridazinone hydrochloride compound and method for producing the same
10/25/2001WO2001079184A1 Substituted piperazine compounds
10/25/2001WO2001079183A1 2-phenyl-2h-pyridazine-3-ones
10/25/2001WO2001079182A1 2-phenyl-2h-pyridazine-3-ones
10/25/2001WO2001079181A2 Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors
10/25/2001WO2001079177A1 Cyclic diaza compounds for treating neurodegenerative disorders
10/25/2001WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001CA2406227A1 2-phenyl-2h-pyridazine-3-ones
10/25/2001CA2406217A1 2-phenyl-2h-pyridazine-3-ones
10/24/2001EP1148053A1 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
10/24/2001EP0835246B1 Aromatic compounds and pharmaceutical compositions containing them
10/24/2001CN1319012A Method for treating diabetes employing ap2 inhibitor and combination
10/23/2001US6307047 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
10/23/2001US6306889 Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
10/18/2001WO2001076530A2 Il-8 receptor antagonists
10/17/2001EP1144436A1 METHOD FOR PREPARING BICYCLIC COMPOUNDS AND USE OF SAID METHOD FOR PREPARING AN INTERLEUKIN-1$g(B) CONVERSION ENZYME (ICE) INHIBITOR
10/17/2001EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144380A1 A meta-nitro phenol derivative and a process for producing it
10/17/2001EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001EP1143944A2 Use of arylalkanoylpyridazines
10/17/2001EP1001955B1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 85